🇺🇸 FDA

Company profile · Sponsor

Amneal

Amneal Pharma Europe Ltd

AMRX · NYSE pharma GB
Pipeline
15
Drugs
12
Patents
8

Quick answer

Amneal (AMRX) is a pharma company. headquartered in GB. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 12 drugs, and 8 patents to this profile..

Company facts

Ticker AMRX
Exchange NYSE
Company type pharma
Headquarters GB
SEC CIK 0001723128

Pipeline (15)

Search pipeline →

  1. Asenapine Sublingual Tablets 10 mg

    Amneal

    Schizophrenia

    phase 3 small molecule completed

    1 trial

  2. Diclofenac Sodium Topical Gel, 1%

    Amneal

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  3. Estradiol Vaginal Tablets 10 mcg

    Amneal

    Atrophic Vaginitis Due to Menopause

    phase 3 small molecule completed

    1 trial

  4. Imatinib Mesylate Tablets, 400 mg

    Amneal

    Chronic Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  5. Mometasone Furoate Nasal Spray, 50 mcg

    Amneal

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  6. Phenazopyridine Hydrochloride

    Amneal

    Pain

    phase 3 small molecule completed

    1 trial

  7. Placebo

    Amneal

    Asthma

    phase 3 small molecule active

    1 trial

  8. Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg

    Amneal

    Uncomplicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  9. Test - Bimatoprost 0.01% Ophthalmic Solution

    Amneal

    Glaucoma, Open-Angle

    phase 3 small molecule active

    1 trial

  10. Test Product

    Amneal

    Asthma

    phase 3 small molecule active

    2 trials

  11. Testosterone Topical Gel, 1.62% Metered Pump

    Amneal

    Primary Hypogonadism

    phase 3 small molecule completed

    1 trial

  12. Bimatoprost Ophthalmic Solution, 0.01%

    Amneal

    Open-angle Glaucoma

    phase 1 small molecule active

    1 trial

  13. KSHN001126 150mg

    Amneal

    Healthy Postmenopausal Women

    phase 1 small molecule completed

    1 trial

  14. Methotrexate - Amneal

    Amneal

    Psoriasis

    phase 1 small molecule active

    1 trial

  15. CREXONT ER

    Amneal

    Parkinson Disease

    approved small molecule active

    2 trials

Drugs (12)

Search drugs →

  1. abiraterone acetate

    ABIRATERONE KRKA

    ORAL approved

    L02BX03

  2. acebutolol hydrochloride

    ACEBUTOLOL HYDROCHLORIDE

    ORAL approved

  3. acyclovir

    ZOVIRAX

    OPHTHALMIC approved

  4. albuterol sulfate

    PROVENTIL

    INHALATION approved

  5. alosetron hydrochloride

    ALOSETRON HYDROCHLORIDE

    ORAL approved

  6. alprazolam

    ALPRAZOLAM

    ORAL approved

  7. aminocaproic acid

    AMINOCAPROIC ACID

    INJECTION approved

  8. amlodipine benzoate

    AMLODIPINE BENZOATE

    ORAL approved

  9. amphetamine sulfate

    AMPHETAMINE SULFATE

    ORAL approved

  10. apremilast

    APREMILAST VIATRIS

    ORAL approved

    L04AA32

  11. argatroban

    ARGATROBAN

    INJECTION approved

  12. aripiprazole

    ABILIFY MYCITE

    INTRAMUSCULAR approved

    N05AX12

Patents (8)

Search patents →

  1. US 12383522

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12370163

    Levodopa dosing regimen

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12303481

    Levodopa dosing regimen

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12303482

    Levodopa dosing regimen

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12295931

    Levodopa dosing regimen

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12263148

    Levodopa dosing regimen

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12263149

    Levodopa dosing regimen

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12233166

    Extended release compositions comprising pyridostigmine

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Amneal?

Amneal (AMRX) is a pharma company. headquartered in GB. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 12 drugs, and 8 patents to this profile..

What pipeline programs does Amneal sponsor?

We track 15 ClinicalTrials.gov-linked programs for Amneal, including Asenapine Sublingual Tablets 10 mg and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Amneal company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.